BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025

Rhea-AI Summary

BioLargo (OTCQX: BLGO) will present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference (NobleCon 21) on December 3, 2025 at 10:30 AM Eastern in Boca Raton, FL.

President & CEO Dennis P. Calvert will address prior-year financial results and ongoing business developments. The conference features formal presentations, fireside chats, one-on-one meetings and networking with hundreds of public company executives and keynote speakers.

Investors can attend the in-person session at Presentation Room 4 or learn more about the conference at nobleconference.com and company technologies at biolargo.com.

Westminster, California--(Newsfile Corp. - November 21, 2025) - BioLargo, Inc. (OTCQX: BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and cleantech problems, today announced it will be presenting at Noble Capital Markets' 21^st Annual Emerging Growth Equity Conference at Florida Atlantic University, College of Business Executive Education in Boca Raton, FL on December 3^rd, 2025 at 10:30 AM Eastern Time. BioLargo President & CEO Dennis P. Calvert will represent the company and address its prior-year financial results and ongoing business developments.

Event: NobleCon 21
Date: December 3rd, 2025
Time: 10:30 AM Eastern
Location: Presentation Room 4

Summary of NobleCon 21
Hundreds of public company executive guest speakers. World class keynotes. Formal presentations, fireside chats, one-on-one meetings. Networking and wind-down events. The premier in-person multi-sector emerging growth equity conference of the year. Keynote address from Bret Baier.

Learn more about NobleCon21: nobleconference.com.

Learn more about BioLargo's environmental technologies at biolargo.com.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX: BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at https://www.biolargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275472

FAQ

When will BioLargo (BLGO) present at NobleCon 21 and where?

BioLargo will present on December 3, 2025 at 10:30 AM Eastern in Presentation Room 4 at Florida Atlantic University, Boca Raton, FL.

Who will represent BioLargo (BLGO) at the December 3, 2025 presentation?

President & CEO Dennis P. Calvert will represent BioLargo and address prior-year financial results and ongoing business developments.

What topics will BioLargo (BLGO) cover at NobleCon 21 on December 3, 2025?

The presentation will cover prior-year financial results and ongoing business developments related to BioLargo's environmental technologies.

Can investors access BioLargo's NobleCon 21 presentation remotely on December 3, 2025?

The announcement notes an in-person presentation; attendees should check nobleconference.com or BioLargo's investor resources at biolargo.com for webcast or replay availability.

How can investors learn more about NobleCon 21 or BioLargo (BLGO) before the December 3, 2025 presentation?

Visit nobleconference.com for conference details and biolargo.com for information on BioLargo's technologies and corporate updates.